Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Imunon, Inc. Director's Dealing 2010

Dec 8, 2010

35124_dirs_2010-12-08_1a51f5a7-db65-4149-944d-7c91d79eacb2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2010-12-06

Reporting Person: Martinez Alberto R (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-12-06 Option to Purchase Celsion Corporation Common Stock $2.81 A 30000 Acquired 2020-12-06 Celsion Corporation Common Stock (30000) Direct

Footnotes

F1: Options vest 1/3 each on December 6, 2011, 2012 and 2013

F2: Fair value on date of stock grant